These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 11929492

  • 1. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma.
    Stelmach I, Jerzynska J, Kuna P.
    Clin Exp Allergy; 2002 Feb; 32(2):264-9. PubMed ID: 11929492
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of triamcinolone acetonide, montelukast, nedocromil sodium and formoterol on eosinophil blood counts, ECP serum levels and clinical progression of asthma in children].
    Stelmach I, Grzelewski T, Stelmach W, Majak P, Jerzyńska J, Górski P, Kuna P.
    Pol Merkur Lekarski; 2002 Mar; 12(69):208-13. PubMed ID: 12053590
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind trial of the effect of treatment with formoterol on clinical and inflammatory parameters of asthma in children.
    Stelmach I, Gorski P, Jerzynska J, Stelmach W, Majak P, Kuna P.
    Ann Allergy Asthma Immunol; 2002 Jul; 89(1):67-73. PubMed ID: 12141723
    [Abstract] [Full Text] [Related]

  • 7. [The effect of triamcinolone acetonide, montelukast, nedocromil sodium, formoterol on levels levels of sICAM-1, sIL-2R in serum and clinical course of asthma in children].
    Stelmach I, Jerzyńska J, Majak P, Grzelewski T, Górski P, Stelmach W, Kuna P.
    Pol Merkur Lekarski; 2002 Feb; 12(68):99-103. PubMed ID: 11995262
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-inflammatory effects of montelukast in mild cystic fibrosis.
    Schmitt-Grohé S, Eickmeier O, Schubert R, Bez C, Zielen S.
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):599-605. PubMed ID: 12487226
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma.
    Strauch E, Moske O, Thoma S, Storm Van's Gravesande K, Ihorst G, Brandis M, Kuehr J.
    Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396
    [Abstract] [Full Text] [Related]

  • 20. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.
    Knorr B, Matz J, Bernstein JA, Nguyen H, Seidenberg BC, Reiss TF, Becker A.
    JAMA; 1998 Apr 15; 279(15):1181-6. PubMed ID: 9555757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.